- Home
- KRRO vs PCF Comparison
KRRO vs PCF Comparison
Compare KRRO & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- PCF
- Stock Information
- Founded
- KRRO 2014
- PCF 1987
- Country
- KRRO United States
- PCF United States
- Employees
- KRRO N/A
- PCF N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- PCF Trusts Except Educational Religious and Charitable
- Sector
- KRRO Health Care
- PCF Finance
- Exchange
- KRRO Nasdaq
- PCF Nasdaq
- Market Cap
- KRRO 209.6M
- PCF 196.9M
- IPO Year
- KRRO 2019
- PCF N/A
- Fundamental
- Price
- KRRO $15.56
- PCF $6.30
- Analyst Decision
- KRRO Strong Buy
- PCF
- Analyst Count
- KRRO 7
- PCF 0
- Target Price
- KRRO $90.67
- PCF N/A
- AVG Volume (30 Days)
- KRRO 102.4K
- PCF 74.8K
- Earning Date
- KRRO 05-07-2025
- PCF 01-01-0001
- Dividend Yield
- KRRO N/A
- PCF 10.90%
- EPS Growth
- KRRO N/A
- PCF N/A
- EPS
- KRRO N/A
- PCF N/A
- Revenue
- KRRO $4,821,000.00
- PCF N/A
- Revenue This Year
- KRRO N/A
- PCF N/A
- Revenue Next Year
- KRRO $55.56
- PCF N/A
- P/E Ratio
- KRRO N/A
- PCF N/A
- Revenue Growth
- KRRO N/A
- PCF N/A
- 52 Week Low
- KRRO $11.13
- PCF $5.71
- 52 Week High
- KRRO $98.00
- PCF $6.96
- Technical
- Relative Strength Index (RSI)
- KRRO 45.62
- PCF 51.96
- Support Level
- KRRO $13.40
- PCF $6.24
- Resistance Level
- KRRO $22.15
- PCF $6.33
- Average True Range (ATR)
- KRRO 2.47
- PCF 0.09
- MACD
- KRRO 0.07
- PCF 0.03
- Stochastic Oscillator
- KRRO 24.69
- PCF 84.06
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.